Stay updated on Atacicept in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Atacicept in IgA Nephropathy Clinical Trial page.

Latest updates to the Atacicept in IgA Nephropathy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded a Locations section with California as a location, and updated the page to revision v3.3.3.SummaryDifference0.2%

- Check29 days agoNo Change Detected
- Check50 days agoChange DetectedPublications section wording now states that publications are automatically filled from PubMed. The revision label was updated to v3.3.2.SummaryDifference0.1%

- Check58 days agoChange DetectedThe funding-lapse warning was removed from the page, removing explicit guidance about information recency and operating status resources. This could affect how users gauge the currency of the displayed study details and where to find status updates.SummaryDifference0.4%

- Check65 days agoChange DetectedA new publication citation was added under Publications: 'A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy' (N Engl J Med, 2025, Online ahead of print).SummaryDifference0.1%

- Check72 days agoChange DetectedThe updates appear to be formatting adjustments and a refreshed update timestamp, with no changes to critical trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check101 days agoChange DetectedAdds an operating-status notice, new dates, and a newer revision; removes older dates and a product-origin statement. The key impact is updating the page’s status and version information.SummaryDifference6%

Stay in the know with updates to Atacicept in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atacicept in IgA Nephropathy Clinical Trial page.